Direktorat Registrasi ObatValid

LAMIVUDINE

BPOM Number: GKL1312425210B1
Approved: 21 November 2024
Expiry: 15 January 2028
Form: TABLET; 150 MG

About This Registration

LAMIVUDINE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1312425210B1. Its current registration status is Valid, with the licence valid until 15 January 2028. The product is registered to KIMIA FARMA TBK. - INDONESIA. BPOM first approved this registration in May 2023. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 1 BOTOL PLASTIK @ 60 TABLET
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

KIMIA FARMA TBK. - INDONESIA
KAB. BANDUNG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

KIMIA FARMA TBK. - INDONESIA
KAB. BANDUNG
primary
View profile →

Ingredients (1)

LAMIVUDINE

Market Intelligence

Owner Portfolio: KIMIA FARMA TBK. - INDONESIA holds 355 BPOM registrations
Manufacturer Scale: KIMIA FARMA TBK. - INDONESIA produces 355 registered products
Registration Age: Registered for 3 years, 4 months